Similar articles for PMID: 15596679

Year	Number of Results
1996	1
1999	2
2000	5
2001	2
2002	5
2003	7
2004	3
2005	3
2006	3
2007	11
2008	6
2009	6
2010	4
2011	6
2012	7
2013	8
2014	6
2015	2
2016	3
2017	3
2018	1
2019	1
2020	1
2021	1
2023	1
2024	0

1

Efficacy of inhaled steroids in undiagnosed subjects at high risk for COPD: results of the detection, intervention, and monitoring of COPD and asthma program.

Albers M, Schermer T, van den Boom G, Akkermans R, van Schayck C, van Herwaarden C, van Weel C. Albers M, et al. Chest. 2004 Dec;126(6):1815-24. doi: 10.1378/chest.126.6.1815. Chest. 2004. PMID: 15596679 Clinical Trial.

2

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS. Zheng JP, et al. Chest. 2007 Dec;132(6):1756-63. doi: 10.1378/chest.06-3009. Epub 2007 Oct 20. Chest. 2007. PMID: 17951625 Clinical Trial.

3

Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme.

den Otter JJ, van Schayck CP, Folgering HT, van den Boom G, Akkermans RP, van Weel C. den Otter JJ, et al. Eur J Gen Pract. 2007;13(2):89-91. doi: 10.1080/13814780701377455. Eur J Gen Pract. 2007. PMID: 17534745 Free article. Clinical Trial.

4

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Celli BR, et al. Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. doi: 10.1164/rccm.200712-1869OC. Epub 2008 May 29. Am J Respir Crit Care Med. 2008. PMID: 18511702 Clinical Trial.

5

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C. Boscia JA, et al. Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11. Clin Ther. 2012. PMID: 22789766 Clinical Trial.

6

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study.

van Grunsven P, Schermer T, Akkermans R, Albers M, van den Boom G, van Schayck O, van Herwaarden C, van Weel C. van Grunsven P, et al. Respir Med. 2003 Dec;97(12):1303-12. doi: 10.1016/j.rmed.2003.08.001. Respir Med. 2003. PMID: 14682412 Free article. Clinical Trial.

7

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.

Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Sanford L, Lettis S, Crim C, Calverley PM. Dransfield MT, et al. Lancet Respir Med. 2013 May;1(3):210-23. doi: 10.1016/S2213-2600(13)70040-7. Epub 2013 Apr 12. Lancet Respir Med. 2013. PMID: 24429127 Clinical Trial.

8

Controlled trial of inhaled fluticasone propionate in moderate to severe COPD.

Thompson WH, Carvalho P, Souza JP, Charan NB. Thompson WH, et al. Lung. 2002;180(4):191-201. doi: 10.1007/s004080000093. Lung. 2002. PMID: 12391509 Clinical Trial.

9

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.

Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C. Ferguson GT, et al. Respir Med. 2008 Aug;102(8):1099-108. doi: 10.1016/j.rmed.2008.04.019. Epub 2008 Jul 9. Respir Med. 2008. PMID: 18614347 Free article. Clinical Trial.

10

Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD.

Hagedorn C, Kässner F, Banik N, Ntampakas P, Fielder K. Hagedorn C, et al. Respir Med. 2013 Apr;107(4):542-9. doi: 10.1016/j.rmed.2012.12.020. Epub 2013 Jan 20. Respir Med. 2013. PMID: 23337300 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year